azimexon has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerner, D; Dziuba-Traber, H; Peter, HH | 1 |
| Advani, SH; Gangal, SG; Ghogale, SR | 1 |
1 trial(s) available for azimexon and Kahler Disease
| Article | Year |
|---|---|
The effect of BM 12.531 (azimexon) on natural killer cell activity in myeloma patients.
Topics: Adjuvants, Immunologic; Aziridines; Azirines; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Humans; Killer Cells, Natural; Leukocyte Count; Melphalan; Multiple Myeloma; Prednisone; Vincristine | 1984 |
1 other study(ies) available for azimexon and Kahler Disease
| Article | Year |
|---|---|
Effect of BM 12531 on rosette formation and in vitro functions of peripheral blood lymphocytes obtained from healthy donors and cancer patients.
Topics: Aziridines; Azirines; Hodgkin Disease; Humans; In Vitro Techniques; Leukocyte Migration-Inhibitory Factors; Multiple Myeloma; Rosette Formation; T-Lymphocytes | 1981 |